The University of Texas MD Anderson Cancer Center plans to expand its global oncology efforts in Mozambique and Brazil, including a new four-year agreement to broaden existing cancer prevention and treatment efforts with the Ministry of Health in Mozambique and a $5.1 million grant from NIH focused on cervical cancer prevention and treatment among women living with the human immunodeficiency virus.
The world of cancer treatments continues to evolve, and for those diagnosed with blood cancers, a new option can be found in menin inhibitors—the latest form of targeted therapy in advanced acute leukemia.
